Antidepressant Medication – First three Months of Treatment
2022-23 Edition
Why is it important to have follow-up visits with your doctor or mental health provider when you are diagnosed with depression?
During the first 3 months of treatment, or the acute phase of depression, it is important to continue the therapy and closely monitor prescribed medications called anti-depressants. The therapy and medications usually take time to have a full effect. Only about half of the people who take anti-depressants finish all of their medicine or take it correctly.
How should doctors help with the treatment of depression?
During the first 3 months after a diagnosis of depression, you and your doctor or mental health provider will develop a treatment plan of therapy, medications or a combination of both. Regular visits during the first 3 months are important to make sure that the treatment is working or to make adjustments in the medications as needed.
Talk with your doctor and health plan to find out about what other services are available. Many health plans offer additional support and resources for depression and other mental health conditions. These additional resources may be educational materials (online and in print), classes or support groups, or phone counseling.
What do the scores mean?
The scores show how well each health plan did at making sure patients diagnosed with depression received treatment during the acute phase (first 12 weeks) following the start of treatment. The higher score means more patients got the right care at the right time.
The scores are based on information from at least 30 health plan member administrative records in 2021.
Data Disclaimer
The source for data contained in this publication is Quality Compass®2022 and is used with the permission of the National Committee for Quality Assurance (NCQA). Quality Compass® 2022 includes certain Consumer Assessment of Healthcare Providers and Systems (CAHPS®) data. Any data display, analysis, interpretation, or conclusion based on these data is solely that of the authors, and NCQA specifically disclaims responsibility for any such display, analysis, interpretation, or conclusion. Quality Compass is a registered trademark of NCQA. CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).
Users of the data shall not have the right to alter, enhance, or otherwise modify the data. Anyone desiring to use or reproduce the data without modification for a noncommercial purpose may do so without obtaining any approval from NCQA. All commercial uses must be approved by NCQA and are subject to a license at the discretion of NCQA. Use by health care providers in connection with their own practices is not commercial use. A "commercial use" refers to any sale, license, or distribution of the data for commercial gain, or incorporation of the data into any product or service that is sold, licensed, or distributed for commercial gain, even if there is no actual charge for inclusion of the data. ©2004-2022 National Committee for Quality Assurance, all rights reserved.